Deanne Randolph | VP, Commercial Development & Head, IR |
Frank Bedu-Addo | President, CEO & Director |
Lauren Wood | Chief Medical Officer |
Seth Van Voorhees | CFO, Principal Financial & Accounting Officer |
Louise Chen | Cantor Fitzgerald |
Leland Gershell | Oppenheimer & Co. Inc. |
Joseph Pantginis | H.C. Wainwright & Co. |
Robert LeBoyer | Noble Capital Markets |
James Molloy | Alliance Global Partners |
Greetings and welcome to PDS Biotechnology Second Quarter 2021 Financial Results. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Deanne Randolph, Vice President of Commercial Development. Please go ahead.
Good morning, and welcome to PDS Biotechnology's second quarter 2021 earnings conference call and audio webcast.